2024
Postvasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit
Gu C, Belarmino A, Kenfield S, Nolte D, Civello D, Smith J, Honig S, Mehta A, Punjani N, Lerner L. Postvasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit. Journal Of Urology 2024, 212: 899-906. PMID: 39093876, DOI: 10.1097/ju.0000000000004185.Peer-Reviewed Original ResearchConceptsPostvasectomy semen analysisUrological practiceLogistic regression modelsPatient compliancePoor patient complianceUnivariate logistic regression modelCompliance rateMultivariate logistic analysisPractice typeSemen analysisKIT activationNationwide cohortProspective dataLogistic analysisRegression modelsPeriod of observationPractice areaWeeksPostvasectomyUrologyPatientsReceive careImpact of relevant variablesKitZip codes
2018
Gender-Affirming Surgery: Current Concepts
Pan S, Honig SC. Gender-Affirming Surgery: Current Concepts. Current Urology Reports 2018, 19: 62. PMID: 29881906, DOI: 10.1007/s11934-018-0809-9.Peer-Reviewed Original ResearchConceptsGender-affirming surgeryGenital gender-affirming surgeryCurrent conceptsColorectal surgeryPerioperative periodGender reassignment surgeryContinued careNotable complicationsSurgical techniqueReconstructive surgerySurgical proceduresTransgender patientsSurgeryMultidisciplinary approachReassignment surgeryUrologistsCareManagement optionsComplicationsPatientsGynecologyUrology
2016
Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States
Rao PK, Boulet SL, Mehta A, Hotaling J, Eisenberg ML, Honig SC, Warner L, Kissin DM, Nangia AK, Ross LS. Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States. Journal Of Urology 2016, 197: 1121-1126. PMID: 27789218, PMCID: PMC11056957, DOI: 10.1016/j.juro.2016.10.063.Peer-Reviewed Original ResearchConceptsTherapy useReproductive-age menTherapy usersMen 18Older menTestosterone replacement therapyTruven Health MarketScanLong-term sequelaeCommercial claims databaseYounger age groupsCochran-Armitage testCross-sectional analysisFourfold increaseMen 56Topical gel formulationTestosterone useClaims databaseReplacement therapySignificant threefold increaseInjection usePractice patternsGel usePoisson regressionAge groupsSemen analysis